Avidity Partners Management LP Sells 40,500 Shares of Humana Inc. (NYSE:HUM)

Avidity Partners Management LP trimmed its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 31.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 89,200 shares of the insurance provider's stock after selling 40,500 shares during the quarter. Humana makes up 2.2% of Avidity Partners Management LP's portfolio, making the stock its 18th biggest position. Avidity Partners Management LP owned 0.07% of Humana worth $22,631,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Aptus Capital Advisors LLC grew its stake in Humana by 12.0% in the fourth quarter. Aptus Capital Advisors LLC now owns 859 shares of the insurance provider's stock worth $218,000 after purchasing an additional 92 shares in the last quarter. Accredited Wealth Management LLC acquired a new position in shares of Humana in the 4th quarter worth approximately $101,000. Solel Partners LP bought a new position in Humana during the fourth quarter worth $1,116,000. Triumph Capital Management increased its stake in Humana by 64.4% during the fourth quarter. Triumph Capital Management now owns 1,639 shares of the insurance provider's stock valued at $416,000 after purchasing an additional 642 shares during the last quarter. Finally, PDT Partners LLC lifted its position in shares of Humana by 118.7% in the 4th quarter. PDT Partners LLC now owns 8,881 shares of the insurance provider's stock worth $2,253,000 after buying an additional 4,821 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Piper Sandler increased their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Barclays boosted their price objective on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research report on Friday, April 11th. JPMorgan Chase & Co. reduced their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, Truist Financial lifted their target price on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Eighteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $287.76.

Humana Trading Down 1.9 %

Shares of HUM stock traded down $4.78 during trading hours on Tuesday, reaching $251.91. 985,406 shares of the stock traded hands, compared to its average volume of 1,749,672. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $30.40 billion, a PE ratio of 25.32, a PEG ratio of 2.05 and a beta of 0.49. The business has a fifty day moving average price of $266.02 and a 200 day moving average price of $270.56.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same period in the previous year, the firm earned $7.23 earnings per share. Humana's quarterly revenue was up 8.4% on a year-over-year basis. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is currently 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.